Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Cost-utility analysis and net monetary benefit of Platelet Rich Plasma (PRP), intra-articular injections in compared to Plasma Rich in Growth Factors (PRGF), Hyaluronic Acid (HA) and ozone in knee osteoarthritis in Iran. | BMC Musculoskelet Disord | 2023 | 36631861 | PubTator, text mining | PubMed |
| Individual immune cell and cytokine profiles determine platelet-rich plasma composition. | Arthritis Res Ther | 2023 | 36627721 | PubTator, text mining | PubMed |
| Proteomics Investigation of Diverse Serological Patterns in COVID-19. | Mol Cell Proteomics | 2023 | 36621767 | PubTator, text mining | PubMed |
Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling. | Neoplasia | 2023 | 36610378 | PubTator, text mining | PubMed |
| Anticardiolipin and anti-beta 2-glycoprotein I antibodies in patients with unexplained articular manifestations. | J Clin Lab Anal | 2023 | 36514859 | PubTator, text mining | PubMed |
| A human monoclonal antibody bivalently binding two different epitopes in streptococcal M protein mediates immune function. | EMBO Mol Med | 2023 | 36507602 | PubTator, text mining | PubMed |
| Interactions of Candida tropicalis pH-related antigen 1 with complement proteins C3, C3b, factor-H, C4BP and complement evasion. | Immunobiology | 2023 | 36495597 | PubTator, text mining | PubMed |
| Association of complement pathways with COVID-19 severity and outcomes. | Microbes Infect | 2023 | 36494054 | PubTator, text mining | PubMed |
| Aging Affects the Efficacy of Platelet-Rich Plasma Treatment for Osteoarthritis. | Am J Phys Med Rehabil | 2023 | 36480365 | PubTator, text mining | PubMed |
| Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming. | Stem Cell Rev Rep | 2023 | 36417151 | PubTator, text mining | PubMed |
| Fortified gelatin-based hydrogel scaffold with simvastatin-mixed nanomicelles and platelet rich plasma as a promising bioimplant for tissue regeneration. | Int J Biol Macromol | 2023 | 36400213 | PubTator, text mining | PubMed |
| Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system. | Immunol Rev | 2023 | 36398537 | PubTator, text mining | PubMed |
| Lactoferrin and the development of salivary stones: a pilot study. | Biometals | 2023 | 36396778 | PubTator, text mining | PubMed |
| Biologic principles of minced cartilage implantation: a narrative review. | Arch Orthop Trauma Surg | 2023 | 36385655 | PubTator, text mining | PubMed |
| Current uses of artificial intelligence in the analysis of biofluid markers involved in corneal and ocular surface diseases: a systematic review. | Eye (Lond) | 2023 | 36380089 | PubTator, text mining | PubMed |
| Alternative pathway activation in pregnancy, a measured amount "complements" a successful pregnancy, too much results in adverse events. | Immunol Rev | 2023 | 36377667 | PubTator, text mining | PubMed |
| Kidney diseases. | Immunol Rev | 2023 | 36369988 | PubTator, text mining | PubMed |
| Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop. | Immunol Rev | 2023 | 36258635 | PubTator, text mining | PubMed |
| Association of Glial Activation and α-Synuclein Pathology in Parkinson's Disease. | Neurosci Bull | 2023 | 36229715 | PubTator, text mining | PubMed |
| Pharmacokinetics of transdermal methyl-, ethyl-, and propylparaben in humans following single dermal administration. | Chemosphere | 2023 | 36220432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=20